Fatal arrhythmias and ventricular fibrillation (VF) which lead to sudden cardiac death are believed to be preceded by alternans, observed as a beat-to-beat variation of the T-wave amplitude on the ECG [1, 2] . Previous studies to predict the onset of alternans involved the restitution curve, the functional relationship between the action potential duration (APD) and preceding diastolic interval (DI). It was hypothesized that alternans appears when the magnitude of the slope of the restitution curve exceeds one [3] . However, this hypothesis failed in various experimental studies [4] . One of the main reasons for failure of the restitution hypothesis was the fact that it was derived under assumption of constant or periodic pacing, where there is an inherent dependence of the DI on the immediate preceding APD. During periodic pacing, small changes in DI are translated into subsequent changes in the APD and thus, enhance instability of cardiac rhythms in the heart. However, under normal physiological conditions, intrinsic heart rate variability (HRV) ensures deviation of the heart from periodic pacing [4] . HRV is a variation in time interval between two consecutive heartbeats. Figure 1 shows a representative example of HRV as a change in RR interval for a normal sinus rhythm of a healthy adult male at rest. We can see that the RR interval, the time duration between two consecutive peaks of the ECG, varies over time.
Background
Fatal arrhythmias and ventricular fibrillation (VF) which lead to sudden cardiac death are believed to be preceded by alternans, observed as a beat-to-beat variation of the T-wave amplitude on the ECG [1, 2] . Previous studies to predict the onset of alternans involved the restitution curve, the functional relationship between the action potential duration (APD) and preceding diastolic interval (DI). It was hypothesized that alternans appears when the magnitude of the slope of the restitution curve exceeds one [3] . However, this hypothesis failed in various experimental studies [4] . One of the main reasons for failure of the restitution hypothesis was the fact that it was derived under assumption of constant or periodic pacing, where there is an inherent dependence of the DI on the immediate preceding APD. During periodic pacing, small changes in DI are translated into subsequent changes in the APD and thus, enhance instability of cardiac rhythms in the heart.
However, under normal physiological conditions, intrinsic heart rate variability (HRV) ensures deviation of the heart from periodic pacing [4] . HRV is a variation in time interval between two consecutive heartbeats. Figure 1 shows a representative example of HRV as a change in RR interval for a normal sinus rhythm of a healthy adult male at rest. We can see that the RR interval, the time duration between two consecutive peaks of the ECG, varies over time. HRV is an important physiological phenomenon contributing to normal cardiac rhythm. There is a complex interplay of various physiological factors in regulating the heart rate. The sympathetic components of the autonomic nervous system tend to increase the heart rate whereas the parasympathetic components have a counter effect. The combination of these two opposing components of the nervous system along with other physiological processes such as respiration and blood pressure regulation leads to HRV. Clinical evidence has shown that low HRV is usually associated with heart disease and is therefore a marker of arrhythmias [6, 8, 9] . Our recent numerical simulations demonstrated that incorporation of HRV into periodic pacing protocol lowers the slope of the restitution curve and prevents the formation of alternans, and therefore can potentially be anti-arrhythmic [7] .
Here we aimed to implement our theoretically designed pacing protocol with HRV in a miniaturized pacemaker developed specifically for implantation in small animals. Pacemakers and implantable cardioverter defibrillators are being therapeutically used in patients to restore normal heart function. The heart rate sensing and pacing schemes in the currently available devices depend on real time tracking of the heart rate and taking compensatory measures on detecting irregular rhythm [10] . However, a pacemaker with a potentially anti-arrhythmic pacing scheme that prevents formation of abnormal cardiac rhythms is yet to be implemented.
We propose to test our pacemaker with novel pacing algorithm in small animals (rats). Therefore, we concentrated on miniaturization of the pacemaker for these purposes. We propose a novel design that combines currently available electrical circuits' theory for radio frequency (RF) telemetry with pacing protocols designed in our lab to validate the hypothesized anti-arrhythmic effects of HRV.
Pacing protocol with HRV
Recently, we designed a potentially anti-arrhythmic pacing protocol that incorporates HRV [7] . Briefly, during periodic pacing, basic cycle length (BCL), i.e. the time interval between two consecutive stimuli, relates a corresponding APD n and DI n from the stimulus n as follows:
APD n + DI n = BCL n .
(1) HRV was modeled by modifying BCL n and perturbing it with a parameter δ [10] :
where δ(HRV) is a random number with a mean of zero and a standard deviation as BCL*HRV. Here HRV was calculated as follows [7] :
where SD RR is the standard deviation and AVG RR is the average of the RR intervals, which was calculated as the distance between RR peaks in the ECG trace (see Figure 1 ).
Miniaturized RF telemetric pacemaker
We developed a miniaturized pacemaker design that incorporates our pacing protocol with HRV. It has the capability for real time heart rate sensing and wireless transmission, enabling control over pacing and capturing paced cardiac data. Figures 2 and 3 show the block diagrams for the pacemaker to be implanted in the animal and the external processor recording the ECG in real time, respectively. The RF transceiver performs the dual function of transmitting real time acquired heart rate signals to and receiving control data from the external processor.
The micro-controller forms the core of the pacemaker. We use Texas Instruments' microcontroller MSP430 programmed with our pacing protocol incorporating HRV.
The sensing circuit tracks the heart rate which is input to the micro-controller. We then extract the intrinsic HRV features from the captured heart rate and use that as a base to model the perturbation parameter δ(HRV) in our protocol.
The microcontroller interfaces with a simple pulse generator circuit based on IC555 as a stable multivibrator that produces pulse width modulated output according to Equation (2) . This output is used to stimulate the heart using a bipolar pacing lead electrode.
In order to verify the anti-arrhythmic effects of HRV, we first induce VF by pacing the heart at a higher than normal rate. The VFis detected using our sensing circuit and to compensate for it and restore normal cardiac rhythm, the pacemaker begins pacing with our programmed protocol with HRV incorporated. This enables us to gauge the effects of HRV on prevention of arrhythmias.
The magnetic reed switch increases the life of the device. In order to save battery power, the pacemaker can be disabled using this switch. When activated, the switch connects the power supply to the rest of the pacemaker circuit and enables device operation. Deactivating the switch will disconnect the battery and turn off the device. An external magnet is used to turn the switch ON or OFF and power the pacemaker as required.
The external processing unit receives the ECG data transmitted by the pacemaker. As shown in Figure 3 , the external processor mainly consists of an RF transceiver with a micro-controller programmed for detecting and analyzing the recorded ECG signals. The captured ECG data can be interfaced to display devices or recorded for further analysis. The external processing unit also has the ability to send feedback or control signals to the pacemaker based on the ECG data recorded.
Results
We performed analyses of ECG traces from two groups of patients, Healthy and Diseased, to quantify the presence of HRV and study its effect in both these groups [7] . We found significantly higher HRV values for Healthy patients compared to Diseased patients. The data is summarized in Table 1 
Interpretation
HRV is known to be an important intrinsic factor in normal cardiac rhythm under physiological conditions [8] , yet its potential anti-arrhythmic role remains unexplored. Our novel design attempts to validate the hypothesized positive role of HRV in arrhythmia prevention. This could be a step forward in the study of prevention of arrhythmias and development of a clinically relevant solution translating theoretical findings into a useful therapeutic device.
